Wegovy vs Ozempic: what is the difference?
The short answer
Wegovy vs Ozempic comes down to the label: both contain semaglutide, but their FDA labels differ. Ozempic is approved for adults with type 2 diabetes. Wegovy is approved for weight reduction, cardiovascular risk reduction and MASH. NovoCare self-pay is $349 a month for the Ozempic 1 mg pen and $349 for the Wegovy 2.4 mg pen.
Key takeaways
- Both contain semaglutide, but they're separate products with separate labels, doses and pens.
- All of Ozempic's approved uses are in adults with type 2 diabetes. It has no weight-loss indication.
- The Wegovy label doesn't recommend using it with other semaglutide products, so the two aren't taken together.
- Paying cash? At 1 mg, both pens are $349 a month through NovoCare.
- No label converts an Ozempic dose into a Wegovy dose. Your prescriber decides where you start.
Ozempic vs Wegovy, side by side
| Ozempic | Wegovy | |
|---|---|---|
| Active ingredient | semaglutide | semaglutide |
| Maker | Novo Nordisk | Novo Nordisk |
| FDA-approved uses |
|
|
| How it is taken | weekly (multi-dose pen); daily (tablet) | weekly (single-dose pen); daily (tablet) |
| Strengths | 0.25 to 9 mg | 0.25 to 25 mg |
| Label starting dose |
|
|
| Cheapest verified self-pay | No self-pay price listed | $299 per fill at 25 mg |
| With covering commercial insurance | No savings-card price listed | $25 with the manufacturer card |
| Medicare GLP-1 Bridge | No | Yes: Single-dose pen (7.2 mg pen is branded WEGOVY HD); Tablet (once daily) |
| Label | Revised: 5/2026 (DailyMed version 20) | Revised: 6/2026 (DailyMed version 19) |
| Reaction | Ozempic 1 mg | Placebo |
|---|---|---|
| Nausea | 20.3% | 6.1% |
| Vomiting | 9.2% | 2.3% |
| Diarrhea | 8.8% | 1.9% |
| Abdominal pain | 5.7% | 4.6% |
| Constipation | 3.1% | 1.5% |
| Reaction | Wegovy injection 2.4 mg once weekly | Placebo |
|---|---|---|
| Nausea | 44% | 16% |
| Diarrhea | 30% | 16% |
| Vomiting | 24% | 6% |
| Constipation | 24% | 11% |
| Abdominal Pain | 20% | 10% |
| Headache | 14% | 10% |
Each table comes from that medicine's own trials. The trials differ in who was studied and for how long, so the percentages are not a head-to-head comparison.
Ozempic and Wegovy are both made by Novo Nordisk, and both contain semaglutide. Each has its own FDA label, and the labels were written for different patients. That difference in approved use drives almost everything else: which doses exist, what your insurer will pay for, and which Medicare route applies.
Which one suits whom?
- You have type 2 diabetes. Ozempic is the brand whose label covers it: blood sugar control, cardiovascular risk reduction and, for the injection, kidney risk reduction in adults with type 2 diabetes and chronic kidney disease. Commercial plans and Medicare Part D treat it as a diabetes medicine.
- The goal is weight reduction and you don’t have diabetes. Wegovy is the brand with that use on its label. It’s also approved to reduce cardiovascular risk in adults with established cardiovascular disease and obesity or overweight, and the injection is approved for noncirrhotic MASH with moderate to advanced liver fibrosis.
- You want a tablet for weight reduction. Wegovy has one, from $149 a month self-pay.
- You’re on Medicare and want treatment for weight management. Wegovy is in the Medicare GLP-1 Bridge. Ozempic isn’t.
- You’re paying cash. At the doses the two pens share, the NovoCare self-pay price is the same.
Which brand you’re prescribed follows from your diagnosis, and that’s your prescriber’s call.
What is each one approved for?
The side-by-side table above lists every approved use. In short, all of Ozempic’s approved uses are in adults with type 2 diabetes. Wegovy’s are weight reduction and long-term maintenance in adults with obesity or with overweight and a weight-related condition (and, for the injection, in patients aged 12 and older with obesity), cardiovascular risk reduction, and MASH for the injection.
Sharing a molecule doesn’t make the two interchangeable on paper. Ozempic has no weight-loss indication. And the Wegovy label says using it with other semaglutide-containing products isn’t recommended, so one is taken in place of the other, never alongside it.
How do the doses and pens differ?
Both pens are injected once weekly, on the same day each week, at any time of day, with or without meals. Both start at 0.25 mg. After that, the ladders part.
Ozempic comes in 0.25 mg, 0.5 mg, 1 mg, 2 mg. After 4 weeks at 0.25 mg, the dose goes to 0.5 mg. It may go to 1 mg and then 2 mg if more blood sugar control is needed, with at least 4 weeks at each step.
Wegovy comes in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, 7.2 mg. Its schedule climbs every 4 weeks through 0.5 mg, 1 mg and 1.7 mg to the usual maintenance dosage (the dose you stay on) of 2.4 mg from week 17. The 7.2 mg pen, sold as Wegovy HD, is an option only for adults taking Wegovy for weight reduction who have tolerated 2.4 mg for at least 4 weeks.
The devices are different as well. An Ozempic pen is multi-dose: the 4 mg/3 mL pen, for example, delivers 4 doses of 1 mg, and NovoFine Plus needles come in the box. A Wegovy pen is for 1 time use only, and a carton holds 4 single-dose pens. Being comfortable with one doesn’t mean you know how to use the other.
Both brands also have a once-daily tablet. Wegovy tablets (1.5 mg, 4 mg, 9 mg, 25 mg) are taken in the morning on an empty stomach with up to 4 ounces of water, followed by a wait of at least 30 minutes. Ozempic tablets (1.5 mg, 4 mg, 9 mg) are taken the same way and sit on a label shared with Rybelsus. The dosing guide shows both ladders in full, and the titration schedule tool puts either one on a calendar.
What does each one cost?
Self-pay prices line up closely, then split at the top doses.
Self-pay through NovoCare. New patients pay $199 a month for the first two fills of Ozempic 0.25 mg or 0.5 mg, then $349. Wegovy has the same introductory offer on its 0.25 mg and 0.5 mg pens: $199, then $349. Ozempic 1 mg is $349 a month, and Wegovy 1 mg, 1.7 mg and 2.4 mg are $349. The highest doses are priced apart: $499 for Ozempic 2 mg and $399 for Wegovy 7.2 mg.
Wegovy tablets. $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg.
Commercial insurance that covers the drug. Each brand’s savings offer brings a fill to as little as $25 for Ozempic and $25 for Wegovy, with a cap on what Novo Nordisk pays each month. Government beneficiaries are excluded from both.
List price. This is the full price before any discount: $1,027.51 per Ozempic pen and $1,349.02 per Wegovy package.
Over a full year at one dose, self-pay comes to $4,537 for Ozempic 1 mg and $4,537 for Wegovy 2.4 mg. The cost calculator prices any dose path, and the Ozempic cost and Wegovy cost pages list the conditions on each offer. TrumpRx shows the same self-pay prices. See how TrumpRx works.
How do insurance and Medicare treat them?
This is where the two brands differ most in practice.
Commercial plans. Coverage of Ozempic for type 2 diabetes is common, though plans often ask for prior authorization (the plan’s approval before it pays) or proof of diagnosis. Wegovy falls under weight-management benefits, which some employers exclude entirely. Call the number on your insurance card and ask about the specific brand for your diagnosis. Our insurance guide and the appeal letter generator cover what to do after a denial.
Medicare. CMS states that type 2 diabetes is an indication eligible for Part D coverage, so Ozempic runs through your Part D plan’s formulary (its list of covered drugs). CMS also says Medicare and Medicaid generally do not cover GLP-1 drugs for the weight loss indication. Wegovy has two routes around that. Part D can cover it for cardiovascular risk reduction in adults with established cardiovascular disease and obesity or overweight. And the Medicare GLP-1 Bridge provides the pen or tablets for weight management at a $50 copay to those who qualify. A type 2 diabetes diagnosis rules a person out of the Bridge. Does Medicare cover Wegovy has the detail.
How do the side effects compare?
Both labels report mostly gastrointestinal (stomach and bowel) reactions, and both carry a boxed warning about the risk of thyroid C-cell tumors. The figures below come from different trials in different patients at different doses, so read each as a description of that brand, not as a contest.
Ozempic. In two placebo-controlled trials in adults with type 2 diabetes, with a mean exposure of 32.9 weeks, nausea was reported by 15.8 percent of patients on 0.5 mg and 20.3 percent on 1 mg, against 6.1 percent on placebo. Vomiting was reported by 5 percent and 9.2 percent (placebo 2.3 percent). The label says 3.1% and 3.8% of patients on the two doses stopped treatment because of gastrointestinal reactions, compared with 0.4% on placebo.
Wegovy. In three placebo-controlled trials in adults with obesity or overweight, treated with the 2.4 mg injection for up to 68 weeks, nausea was reported by 44 percent of patients against 16 percent on placebo, and vomiting by 24 percent against 6 percent. In those trials, 6.8% of patients on Wegovy and 3.2% on placebo permanently stopped treatment because of adverse reactions.
The Wegovy trials used a higher dose, ran longer and enrolled a different population, which is why the two sets of numbers can’t be set against each other. Each brand’s full label table is on this page, and the side effects guide explains the warnings.
Switching between Ozempic and Wegovy
People move between these two brands when a diagnosis, a goal or a coverage decision changes. The labels give little help with the details. The Ozempic injection label has no instructions for switching from another GLP-1 medicine. It gives only its own starting dose. The Wegovy label’s switching section deals with moving between Wegovy injection and Wegovy tablets, not with arriving from Ozempic.
So there’s no label table that turns an Ozempic dose into a Wegovy dose, and we don’t offer one. Your prescriber decides where you start and writes a new prescription. Our page on switching from Ozempic to Wegovy sets out what both labels say, and the switching planner shows the before and after cost.
Frequently asked questions
Is Wegovy just a higher dose of Ozempic?
No. Both contain semaglutide, but they're separate products with separate labels. The Ozempic pen's strengths are 0.25 mg, 0.5 mg, 1 mg, 2 mg and its approved uses are in type 2 diabetes. The Wegovy pen's strengths are 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, 7.2 mg and its label covers weight reduction and cardiovascular risk reduction. The pens are built differently too: Ozempic's is multi-dose, and Wegovy's is single-dose.
Is Ozempic approved for weight loss?
No weight-loss use appears among Ozempic's indications. Every approved use on the Ozempic label is in adults with type 2 diabetes: blood sugar control, cardiovascular risk reduction and, for the injection, kidney risk reduction in chronic kidney disease. The semaglutide brand whose label covers long-term weight reduction is Wegovy.
Is Ozempic cheaper than Wegovy?
On self-pay through NovoCare, the two pens cost the same at shared doses: $349 a month for Ozempic 1 mg and for Wegovy 1 mg, 1.7 mg and 2.4 mg. The top doses differ: Ozempic 2 mg is $499 and Wegovy 7.2 mg is $399. Wegovy tablets start lower, at $149 a month.
Can I take Ozempic and Wegovy together?
The Wegovy label says no. Its limitations of use state that taking Wegovy tablets or Wegovy injection together with other semaglutide-containing products, or with any other GLP-1 receptor agonist, is not recommended. Ozempic is a semaglutide-containing product, so the two are alternatives, not a combination.
Can I switch from Ozempic to Wegovy?
A prescriber can move you from one to the other, but neither label gives a schedule for it. The Wegovy label's switching section covers only moves between Wegovy injection and Wegovy tablets, and the Ozempic injection label has no switching instructions at all. No label converts an Ozempic dose into a Wegovy dose, so your prescriber decides where you start.
Does Medicare cover Ozempic or Wegovy?
For Ozempic, CMS lists type 2 diabetes as an indication eligible for Part D coverage, so it goes through your Part D plan. For Wegovy, Part D can cover the cardiovascular risk use, and the Medicare GLP-1 Bridge covers the pen and tablets for weight management at a $50 copay for people who meet its criteria. Ozempic isn't a Bridge product.
Sources (21)
- 1.FDA label (DailyMed): Wegovy prescribing information, section 1
“Concomitant use of WEGOVY (semaglutide) tablets or WEGOVY (semaglutide) injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.”
- 2.FDA label (DailyMed): Ozempic prescribing information, section 2.1
“Administer OZEMPIC once weekly, on the same day each week, at any time of the day, with or without meals.”
- 3.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Administer WEGOVY injection once weekly, on the same day each week, at any time of day, with or without meals.”
- 4.FDA label (DailyMed): Ozempic prescribing information, section 3
“Injection: 2 mg/3 mL (0.68 mg/mL) for 4 doses of 0.25 mg and 2 doses of 0.5 mg or 4 doses of 0.5 mg, 4 mg/3 mL (1.34 mg/mL) for 4 doses of 1 mg, and 8 mg/3 mL (2.68 mg/mL) for 4 doses of 2 mg in single-patient-use pens”
- 5.FDA label (DailyMed): Ozempic prescribing information, Instructions for Use
“NovoFine® Plus 32G 4 mm disposable needles are included with your OZEMPIC pen.”
- 6.FDA label (DailyMed): Wegovy prescribing information, Instructions for Use (single-dose pen)
“Your WEGOVY pen is for 1 time use only. The WEGOVY pen is for subcutaneous (under the skin) use only.”
- 7.FDA label (DailyMed): Wegovy prescribing information, section 16
“WEGOVY injection is a clear, colorless solution available in cartons containing 4 single-dose pens, 4 single-dose syringes with integrated needles, or 1 single-patient-use pen (WEGOVY FlexTouch) as follows:”
- 8.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Take one WEGOVY tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces). Do not take WEGOVY tablets with other liquids besides water”
- 9.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“After taking a WEGOVY tablet, wait at least 30 minutes before eating food, drinking beverages or taking other oral medications”
- 10.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“Take one RYBELSUS or OZEMPIC tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces of water). Do not take RYBELSUS or OZEMPIC tablets with other liquids besides water”
- 11.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“After taking RYBELSUS or OZEMPIC tablets, wait at least 30 minutes before eating food, drinking beverages or taking other oral medications”
- 12.CMS: Information for Part D Plans
“Type 2 diabetes, moderate to severe obstructive sleep apnea, and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis) indications are eligible for Part D coverage. [...] If a Medicare Part D beneficiary has a prescription for a GLP-1 drug for an indication covered under Medicare Part D, they should continue to obtain their GLP-1 through their Part D plan.”
- 13.CMS: Information for Part D Plans
“Beneficiaries who are prescribed an eligible GLP-1 drug for a use that is coverable under the basic Medicare Part D benefit, regardless of whether the eligible GLP-1 drug is on the Part D plan’s formulary (e.g., Zepbound® for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity; Wegovy® to reduce the risk of major adverse cardiovascular (CV) events in adults with established CV disease and either obesity or overweight) would not qualify for coverage of that eligible GLP-1 drug under the Medicare GLP-1 Bridge. Part D plan sponsors must continue to follow their existing formulary exception processes for these requests.”
- 14.CMS: BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model
“GLP-1 drugs for weight loss, along with lifestyle interventions, can help people improve their overall health, but GLP-1s are expensive and currently Medicare and Medicaid generally do not cover these drugs for the weight loss indication.”
- 15.
- 16.
- 17.
- 18.
- 19.
- 20.
- 21.
Related pages
- What is Ozempic? Uses, doses, cost and how to take it
- What is Wegovy? Uses, doses, pill and pen, and cost
- Ozempic cost: how much is Ozempic with and without insurance?
- Wegovy cost: pen and pill prices with and without insurance
- Tirzepatide vs semaglutide: how to compare Zepbound, Wegovy, Ozempic and the rest
- Cost calculator
